{"transactions":[{"id":2918592,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2021-01-05T22:11:03.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":2513,"price":4.1337,"value":10387.9881,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 4, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average.  These shares were sold in multiple transactions at prices ranging from $4.05 to $4.25, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001615594-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559421000002/primary_doc.xml","form_type":"4"}},{"id":2935741,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2020-12-21T22:08:46.000Z","date":"2020-12-18","kind":"sale","acquired":false,"shares":5026,"price":4.75,"value":23873.5,"ownership":{"direct":true},"balance_after":2513,"source":{"system":"sec-edgar","filing":"0001615594-20-000077","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559420000077/primary_doc.xml","form_type":"4"}},{"id":3064423,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right-to-Buy)","published_at":"2020-08-07T22:26:21.000Z","date":"2020-08-04","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant."}],"balance_after":65000,"derivative":{"exercise_price":4.55,"exercise_date":"2021-08-04","expiration_date":"2030-08-04","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001615594-20-000052","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559420000052/primary_doc.xml","form_type":"4"}},{"id":3470290,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2019-07-02T17:09:07.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"50,000 Restricted Stock Units with respect to Calyxt Inc. common stock were granted to reporting person on 6/28/2019 and vest as to 15% of the underlying shares on the first anniversary of the Grant Date, as to 10% of the underlying shares on the second anniversary of the Grant Date, and as to 5% of the underlying shares on the last day of each calendar quarter beginning the first full quarter after the second anniversary of the Grant Date."}],"balance_after":142982,"source":{"system":"sec-edgar","filing":"0001615594-19-000027","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559419000027/primary_doc.xml","form_type":"4"}},{"id":3525487,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-15T22:10:59.000Z","date":"2019-05-13","kind":"grant","acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option was granted on May 13, 2019 and vests 15% on the first anniversary of the grant date and 10% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 45 months (commencing on September 30, 2021)."}],"balance_after":68000,"derivative":{"exercise_price":15.28,"expiration_date":"2029-05-13","underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001127602-19-018609","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219018609/form4.xml","form_type":"4"}},{"id":3545249,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-30T20:26:39.000Z","date":"2019-04-29","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option to purchase shares of Calyxt, Inc. common stock (\"Stock Option\") was granted on April 7, 2016 and vested 20% on the grant date and 10% on April 7, 2017, with the remainder vesting quarterly in equal installments over the following 42 months, 25% of which vested immediately on July 25, 2017 when Calyxt, Inc. underwent its initial public offering."}],"balance_after":204611,"derivative":{"exercise_price":3.59,"expiration_date":"2026-04-07","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001127602-19-016564","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219016564/form4.xml","form_type":"4"}},{"id":3545248,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2019-04-30T20:26:39.000Z","date":"2019-04-29","kind":"sale","acquired":false,"shares":3750,"price":16.3073,"value":61152.375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.61, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-19-016564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219016564/form4.xml","form_type":"4"}},{"id":3545247,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2019-04-30T20:26:39.000Z","date":"2019-04-29","kind":"exercise","acquired":true,"shares":3750,"price":3.59,"value":13462.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":96732,"source":{"system":"sec-edgar","filing":"0001127602-19-016564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219016564/form4.xml","form_type":"4"}},{"id":3630850,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-26T23:44:22.000Z","date":"2019-02-25","kind":"exercise","acquired":false,"shares":3977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option to purchase shares of Calyxt, Inc. common stock (\"Stock Option\") was granted on December 3, 2014 and vested 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vested quarterly in equal installments thereafter, 15% of which vested immediately on July 25, 2017 when Calyxt, Inc. underwent its initial public offering."}],"balance_after":208361,"derivative":{"exercise_price":3.59,"expiration_date":"2026-04-07","underlying":"Common Stock","underlying_shares":3977},"source":{"system":"sec-edgar","filing":"0001127602-19-008461","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219008461/form4.xml","form_type":"4"}},{"id":3630849,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2019-02-26T23:44:22.000Z","date":"2019-02-25","kind":"sale","acquired":false,"shares":3977,"price":16,"value":63632.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-19-008461","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219008461/form4.xml","form_type":"4"}},{"id":3630848,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2019-02-26T23:44:22.000Z","date":"2019-02-25","kind":"exercise","acquired":true,"shares":3977,"price":3.59,"value":14277.43,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":96959,"source":{"system":"sec-edgar","filing":"0001127602-19-008461","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219008461/form4.xml","form_type":"4"}},{"id":3676647,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-04T22:41:47.000Z","date":"2019-02-01","kind":"exercise","acquired":false,"shares":4087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option to purchase shares of Calyxt, Inc. common stock (\"Stock Option\") was granted on December 3, 2014 and vested 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vested quarterly in equal installments thereafter, 15% of which vested immediately on July 25, 2017 when Calyxt, Inc. underwent its initial public offering."}],"balance_after":4083,"derivative":{"exercise_price":3.7143,"expiration_date":"2024-12-03","underlying":"Common Stock","underlying_shares":4087},"source":{"system":"sec-edgar","filing":"0001127602-19-003835","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219003835/form4.xml","form_type":"4"}},{"id":3676646,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-04T22:41:47.000Z","date":"2019-01-31","kind":"exercise","acquired":false,"shares":4083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option to purchase shares of Calyxt, Inc. common stock (\"Stock Option\") was granted on December 3, 2014 and vested 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vested quarterly in equal installments thereafter, 15% of which vested immediately on July 25, 2017 when Calyxt, Inc. underwent its initial public offering."}],"balance_after":8170,"derivative":{"exercise_price":3.7143,"expiration_date":"2024-12-03","underlying":"Common Stock","underlying_shares":4083},"source":{"system":"sec-edgar","filing":"0001127602-19-003835","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219003835/form4.xml","form_type":"4"}},{"id":3676645,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2019-02-04T22:41:47.000Z","date":"2019-02-01","kind":"sale","acquired":false,"shares":4087,"price":13,"value":53131.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-19-003835","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219003835/form4.xml","form_type":"4"}},{"id":3676644,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2019-02-04T22:41:47.000Z","date":"2019-02-01","kind":"exercise","acquired":true,"shares":4087,"price":3.7143,"value":15180.3441,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":97069,"source":{"system":"sec-edgar","filing":"0001127602-19-003835","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219003835/form4.xml","form_type":"4"}},{"id":3676643,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2019-02-04T22:41:47.000Z","date":"2019-01-31","kind":"sale","acquired":false,"shares":4083,"price":13,"value":53079.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-19-003835","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219003835/form4.xml","form_type":"4"}},{"id":3676642,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2019-02-04T22:41:47.000Z","date":"2019-01-31","kind":"exercise","acquired":true,"shares":4083,"price":3.7143,"value":15165.4869,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":97065,"source":{"system":"sec-edgar","filing":"0001127602-19-003835","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219003835/form4.xml","form_type":"4"}},{"id":3723095,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-20T21:16:42.000Z","date":"2018-12-18","kind":"exercise","acquired":false,"shares":4083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option to purchase shares of Calyxt, Inc. common stock (\"Stock Option\") was granted on December 3, 2014, and vests 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vesting quarterly in equal installments over the following three years (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":12253,"derivative":{"exercise_price":3.7143,"expiration_date":"2024-12-03","underlying":"Common Stock","underlying_shares":4083},"source":{"system":"sec-edgar","filing":"0001127602-18-036959","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218036959/form4.xml","form_type":"4"}},{"id":3723094,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-12-20T21:16:42.000Z","date":"2018-12-18","kind":"sale","acquired":false,"shares":4083,"price":13,"value":53079.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-18-036959","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218036959/form4.xml","form_type":"4"}},{"id":3723093,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-12-20T21:16:42.000Z","date":"2018-12-18","kind":"exercise","acquired":true,"shares":4083,"price":3.7143,"value":15165.4869,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":97065,"source":{"system":"sec-edgar","filing":"0001127602-18-036959","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218036959/form4.xml","form_type":"4"}},{"id":3766190,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-13T13:59:03.000Z","date":"2018-11-08","kind":"exercise","acquired":false,"shares":4083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option to purchase shares of Calyxt, Inc. common stock (\"Stock Option\") was granted on December 3, 2014, and vests 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vesting quarterly in equal installments over the following three years (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":16336,"derivative":{"exercise_price":3.7143,"expiration_date":"2024-12-03","underlying":"Common Stock","underlying_shares":4083},"source":{"system":"sec-edgar","filing":"0001127602-18-032714","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218032714/form4.xml","form_type":"4"}},{"id":3766189,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-11-13T13:59:03.000Z","date":"2018-11-08","kind":"sale","acquired":false,"shares":4083,"price":13,"value":53079.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-18-032714","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218032714/form4.xml","form_type":"4"}},{"id":3766188,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-11-13T13:59:03.000Z","date":"2018-11-08","kind":"exercise","acquired":true,"shares":4083,"price":3.7143,"value":15165.4869,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":97065,"source":{"system":"sec-edgar","filing":"0001127602-18-032714","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218032714/form4.xml","form_type":"4"}},{"id":3792225,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-11T20:04:41.000Z","date":"2018-10-09","kind":"exercise","acquired":false,"shares":4083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option to purchase shares of Calyxt, Inc. common stock (\"Stock Option\") was granted on December 3, 2014, and vests 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vesting quarterly in equal installments over the following three years (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":20419,"derivative":{"exercise_price":3.7143,"expiration_date":"2024-12-03","underlying":"Common Stock","underlying_shares":4083},"source":{"system":"sec-edgar","filing":"0001127602-18-030029","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218030029/form4.xml","form_type":"4"}},{"id":3792224,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-10-11T20:04:41.000Z","date":"2018-10-09","kind":"sale","acquired":false,"shares":4083,"price":13.8414,"value":56514.4362,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.72 to $14.11, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-18-030029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218030029/form4.xml","form_type":"4"}},{"id":3792223,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-10-11T20:04:41.000Z","date":"2018-10-09","kind":"exercise","acquired":true,"shares":4083,"price":3.7143,"value":15165.4869,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":97065,"source":{"system":"sec-edgar","filing":"0001127602-18-030029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218030029/form4.xml","form_type":"4"}},{"id":3809667,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-21T20:09:42.000Z","date":"2018-09-20","kind":"exercise","acquired":false,"shares":4666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option was granted on April 7, 2016 and vests 20% on the grant date and 10% on the first anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":212338,"derivative":{"exercise_price":3.59,"expiration_date":"2026-04-07","underlying":"Common Stock","underlying_shares":4666},"source":{"system":"sec-edgar","filing":"0001127602-18-028219","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218028219/form4.xml","form_type":"4"}},{"id":3809666,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-09-21T20:09:42.000Z","date":"2018-09-20","kind":"sale","acquired":false,"shares":4666,"price":16,"value":74656.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-18-028219","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218028219/form4.xml","form_type":"4"}},{"id":3809665,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-09-21T20:09:42.000Z","date":"2018-09-20","kind":"exercise","acquired":true,"shares":4666,"price":3.59,"value":16750.94,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":97648,"source":{"system":"sec-edgar","filing":"0001127602-18-028219","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218028219/form4.xml","form_type":"4"}},{"id":3819193,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-11T21:20:12.000Z","date":"2018-09-10","kind":"exercise","acquired":false,"shares":4083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option to purchase shares of Calyxt, Inc. common stock (\"Stock Option\") was granted on December 3, 2014, and vests 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vesting quarterly in equal installments over the following three years (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":24502,"derivative":{"exercise_price":3.7143,"expiration_date":"2024-12-03","underlying":"Common Stock","underlying_shares":4083},"source":{"system":"sec-edgar","filing":"0001127602-18-027365","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218027365/form4.xml","form_type":"4"}},{"id":3819192,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-09-11T21:20:12.000Z","date":"2018-09-10","kind":"sale","acquired":false,"shares":4083,"price":16.1259,"value":65842.0497,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $15.79 to $16.62, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-18-027365","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218027365/form4.xml","form_type":"4"}},{"id":3819191,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-09-11T21:20:12.000Z","date":"2018-09-10","kind":"exercise","acquired":true,"shares":4083,"price":3.7143,"value":15165.4869,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":97065,"source":{"system":"sec-edgar","filing":"0001127602-18-027365","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218027365/form4.xml","form_type":"4"}},{"id":3835518,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-22T20:58:02.000Z","date":"2018-08-20","kind":"exercise","acquired":false,"shares":4666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option was granted on April 7, 2016 and vests 20% on the grant date and 10% on the first anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":217004,"derivative":{"exercise_price":3.59,"expiration_date":"2026-04-07","underlying":"Common Stock","underlying_shares":4666},"source":{"system":"sec-edgar","filing":"0001127602-18-026014","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218026014/form4.xml","form_type":"4"}},{"id":3835517,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-08-22T20:58:02.000Z","date":"2018-08-20","kind":"sale","acquired":false,"shares":4666,"price":17.31,"value":80768.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $17.03 to $17.67, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-18-026014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218026014/form4.xml","form_type":"4"}},{"id":3835516,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-08-22T20:58:02.000Z","date":"2018-08-20","kind":"exercise","acquired":true,"shares":4666,"price":3.59,"value":16750.94,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":97648,"source":{"system":"sec-edgar","filing":"0001127602-18-026014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218026014/form4.xml","form_type":"4"}},{"id":3847014,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-10T18:22:51.000Z","date":"2018-08-08","kind":"exercise","acquired":false,"shares":4083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option to purchase shares of Calyxt, Inc. common stock (\"Stock Option\") was granted on December 3, 2014, and vests 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vesting quarterly in equal installments over the following three years (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":28585,"derivative":{"exercise_price":3.7143,"expiration_date":"2024-12-03","underlying":"Common Stock","underlying_shares":4083},"source":{"system":"sec-edgar","filing":"0001127602-18-025119","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218025119/form4.xml","form_type":"4"}},{"id":3847013,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-08-10T18:22:51.000Z","date":"2018-08-08","kind":"sale","acquired":false,"shares":4083,"price":17.4804,"value":71372.4732,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $17.25 to $17.98, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-18-025119","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218025119/form4.xml","form_type":"4"}},{"id":3847012,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-08-10T18:22:51.000Z","date":"2018-08-08","kind":"exercise","acquired":true,"shares":4083,"price":3.7143,"value":15165.4869,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":97065,"source":{"system":"sec-edgar","filing":"0001127602-18-025119","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218025119/form4.xml","form_type":"4"}},{"id":3862053,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-25T00:20:29.000Z","date":"2018-07-20","kind":"exercise","acquired":false,"shares":4666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option was granted on April 7, 2016 and vests 20% on the grant date and 10% on the first anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":221670,"derivative":{"exercise_price":3.59,"expiration_date":"2026-04-07","underlying":"Common Stock","underlying_shares":4666},"source":{"system":"sec-edgar","filing":"0001127602-18-023818","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218023818/form4a.xml","form_type":"4/A","original_submission_date":"2018-07-24"}},{"id":3862052,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-07-25T00:20:29.000Z","date":"2018-07-20","kind":"sale","acquired":false,"shares":4666,"price":17.94,"value":83708.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-18-023818","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218023818/form4a.xml","form_type":"4/A","original_submission_date":"2018-07-24"}},{"id":3862051,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-07-25T00:20:29.000Z","date":"2018-07-20","kind":"exercise","acquired":true,"shares":4666,"price":3.59,"value":16750.94,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":97648,"source":{"system":"sec-edgar","filing":"0001127602-18-023818","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218023818/form4a.xml","form_type":"4/A","original_submission_date":"2018-07-24"}},{"id":3862050,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-25T00:03:33.000Z","date":"2018-07-20","kind":"exercise","acquired":false,"shares":4666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option was granted on April 7, 2016 and vests 20% on the grant date and 10% on the first anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":221670,"derivative":{"exercise_price":3.59,"expiration_date":"2026-04-07","underlying":"Common Stock","underlying_shares":4666},"source":{"system":"sec-edgar","filing":"0001127602-18-023816","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218023816/form4.xml","form_type":"4"}},{"id":3862049,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-07-25T00:03:33.000Z","date":"2018-07-20","kind":"sale","acquired":false,"shares":4666,"price":17.94,"value":83708.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Includes 100,521 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and vest 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-18-023816","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218023816/form4.xml","form_type":"4"}},{"id":3862048,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-07-25T00:03:33.000Z","date":"2018-07-20","kind":"exercise","acquired":true,"shares":4666,"price":3.59,"value":16750.94,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Includes 100,521 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and vest 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":97648,"source":{"system":"sec-edgar","filing":"0001127602-18-023816","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218023816/form4.xml","form_type":"4"}},{"id":3869066,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-11T20:08:32.000Z","date":"2018-07-09","kind":"exercise","acquired":false,"shares":4083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option to purchase shares of Calyxt, Inc. common stock (\"Stock Option\") was granted on December 3, 2014, and vests 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vesting quarterly in equal installments over the following three years (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":32668,"derivative":{"exercise_price":3.7143,"expiration_date":"2024-12-03","underlying":"Common Stock","underlying_shares":4083},"source":{"system":"sec-edgar","filing":"0001127602-18-023108","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218023108/form4.xml","form_type":"4"}},{"id":3869065,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-07-11T20:08:32.000Z","date":"2018-07-09","kind":"sale","acquired":false,"shares":4083,"price":17.8355,"value":72822.3465,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $17.75 to $18.16, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-18-023108","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218023108/form4.xml","form_type":"4"}},{"id":3869064,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-07-11T20:08:32.000Z","date":"2018-07-09","kind":"exercise","acquired":true,"shares":4083,"price":3.7143,"value":15165.4869,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":97065,"source":{"system":"sec-edgar","filing":"0001127602-18-023108","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218023108/form4.xml","form_type":"4"}},{"id":3884676,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-22T19:53:55.000Z","date":"2018-06-20","kind":"exercise","acquired":false,"shares":4666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option was granted on April 7, 2016 and vests 20% on the grant date and 10% on the first anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":226336,"derivative":{"exercise_price":3.59,"expiration_date":"2026-04-07","underlying":"Common Stock","underlying_shares":4666},"source":{"system":"sec-edgar","filing":"0001127602-18-021750","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218021750/form4.xml","form_type":"4"}},{"id":3884675,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-06-22T19:53:55.000Z","date":"2018-06-20","kind":"sale","acquired":false,"shares":4666,"price":20.555,"value":95909.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $20.395 to $20.765, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-18-021750","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218021750/form4.xml","form_type":"4"}},{"id":3884674,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-06-22T19:53:55.000Z","date":"2018-06-20","kind":"exercise","acquired":true,"shares":4666,"price":3.59,"value":16750.94,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":97648,"source":{"system":"sec-edgar","filing":"0001127602-18-021750","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218021750/form4.xml","form_type":"4"}},{"id":3891996,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-06-15T22:31:44.000Z","date":"2018-06-15","kind":"sale","acquired":false,"shares":7539,"price":19.49,"value":146935.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of shares to Cellectis, S.A. pursuant to a Share Purchase Agreement, dated June 13, 2018, among the reporting person, Cellectis, S.A. and the issuer to cover tax obligations of the reporting person in connection with the vesting on June 14, 2018 of restricted stock units (\"RSUs\") granted by the issuer to the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 85,443 RSUs with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":92982,"source":{"system":"sec-edgar","filing":"0001127602-18-021074","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218021074/form4.xml","form_type":"4"}},{"id":3919942,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-23T19:16:04.000Z","date":"2018-05-21","kind":"exercise","acquired":false,"shares":4666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option was granted on April 7, 2016 and vests 20% on the grant date and 10% on the first anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":231002,"derivative":{"exercise_price":3.59,"expiration_date":"2026-04-07","underlying":"Common Stock","underlying_shares":4666},"source":{"system":"sec-edgar","filing":"0001127602-18-018535","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218018535/form4.xml","form_type":"4"}},{"id":3919941,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-05-23T19:16:04.000Z","date":"2018-05-21","kind":"sale","acquired":false,"shares":4666,"price":16.6286,"value":77589.0476,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50-$16.76, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,521 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and vest 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":100521,"source":{"system":"sec-edgar","filing":"0001127602-18-018535","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218018535/form4.xml","form_type":"4"}},{"id":3919940,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-05-23T19:16:04.000Z","date":"2018-05-21","kind":"exercise","acquired":true,"shares":4666,"price":3.59,"value":16750.94,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,521 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and vest 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":105187,"source":{"system":"sec-edgar","filing":"0001127602-18-018535","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218018535/form4.xml","form_type":"4"}},{"id":3938301,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-10T22:09:58.000Z","date":"2018-05-08","kind":"exercise","acquired":false,"shares":4083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option to purchase shares of Calyxt, Inc. common stock (\"Stock Option\") was granted on December 3, 2014, and vests 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vesting quarterly in equal installments over the following three years (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":36751,"derivative":{"exercise_price":3.7143,"expiration_date":"2024-12-03","underlying":"Common Stock","underlying_shares":4083},"source":{"system":"sec-edgar","filing":"0001127602-18-017122","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218017122/form4.xml","form_type":"4"}},{"id":3938300,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-05-10T22:09:58.000Z","date":"2018-05-08","kind":"sale","acquired":false,"shares":4083,"price":15.5757,"value":63595.5831,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $15.12-$16.15, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,521 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and vest 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":100521,"source":{"system":"sec-edgar","filing":"0001127602-18-017122","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218017122/form4.xml","form_type":"4"}},{"id":3938299,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-05-10T22:09:58.000Z","date":"2018-05-08","kind":"exercise","acquired":true,"shares":4083,"price":3.7143,"value":15165.4869,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,521 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and vest 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":104604,"source":{"system":"sec-edgar","filing":"0001127602-18-017122","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218017122/form4.xml","form_type":"4"}},{"id":3957852,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-24T22:13:04.000Z","date":"2018-04-20","kind":"exercise","acquired":false,"shares":4666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option was granted on April 7, 2016 and vests 20% on the grant date and 10% on the first anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":235668,"derivative":{"exercise_price":3.59,"expiration_date":"2026-04-07","underlying":"Common Stock","underlying_shares":4666},"source":{"system":"sec-edgar","filing":"0001127602-18-015184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218015184/form4.xml","form_type":"4"}},{"id":3957851,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-04-24T22:13:04.000Z","date":"2018-04-20","kind":"sale","acquired":false,"shares":4666,"price":16.8669,"value":78700.9554,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $16.7001-$16.92, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,521 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and vest 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":100521,"source":{"system":"sec-edgar","filing":"0001127602-18-015184","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218015184/form4.xml","form_type":"4"}},{"id":3957850,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-04-24T22:13:04.000Z","date":"2018-04-20","kind":"exercise","acquired":true,"shares":4666,"price":3.59,"value":16750.94,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,521 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and vest 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":105187,"source":{"system":"sec-edgar","filing":"0001127602-18-015184","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218015184/form4.xml","form_type":"4"}},{"id":3965141,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-11T23:47:50.000Z","date":"2018-04-09","kind":"exercise","acquired":false,"shares":4083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option to purchase shares of Calyxt, Inc. common stock (\"Stock Option\") was granted on December 3, 2014, and vests 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vesting quarterly in equal installments over the following three years (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":40834,"derivative":{"exercise_price":3.7143,"expiration_date":"2024-12-03","underlying":"Common Stock","underlying_shares":4083},"source":{"system":"sec-edgar","filing":"0001127602-18-014419","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218014419/form4.xml","form_type":"4"}},{"id":3965140,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-04-11T23:47:50.000Z","date":"2018-04-09","kind":"sale","acquired":false,"shares":4083,"price":14.3849,"value":58733.5467,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $14.04-$14.97, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,521 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and vest 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":100521,"source":{"system":"sec-edgar","filing":"0001127602-18-014419","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218014419/form4.xml","form_type":"4"}},{"id":3965139,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-04-11T23:47:50.000Z","date":"2018-04-09","kind":"exercise","acquired":true,"shares":4083,"price":3.7143,"value":15165.4869,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,521 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and vest 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":104604,"source":{"system":"sec-edgar","filing":"0001127602-18-014419","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218014419/form4.xml","form_type":"4"}},{"id":3984740,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-22T23:25:03.000Z","date":"2018-03-20","kind":"exercise","acquired":false,"shares":4666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option was granted on April 7, 2016 and vests 20% on the grant date and 10% on the first anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":240334,"derivative":{"exercise_price":3.59,"expiration_date":"2026-04-07","underlying":"Common Stock","underlying_shares":4666},"source":{"system":"sec-edgar","filing":"0001127602-18-012594","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218012594/form4.xml","form_type":"4"}},{"id":3984739,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-03-22T23:25:03.000Z","date":"2018-03-20","kind":"sale","acquired":false,"shares":4666,"price":17.9084,"value":83560.5944,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $17.50-$18.35, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-18-012594","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218012594/form4.xml","form_type":"4"}},{"id":3984738,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-03-22T23:25:03.000Z","date":"2018-03-20","kind":"exercise","acquired":true,"shares":4666,"price":3.5878,"value":16740.6748,"ownership":{"direct":true},"balance_after":4666,"source":{"system":"sec-edgar","filing":"0001127602-18-012594","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218012594/form4.xml","form_type":"4"}},{"id":3997522,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-13T22:25:50.000Z","date":"2018-03-08","kind":"exercise","acquired":false,"shares":4083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option to purchase shares of Calyxt, Inc. common stock (\"Stock Option\") was granted on December 3, 2014, and vests 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vesting quarterly in equal installments over the following three years (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."}],"balance_after":44917,"derivative":{"exercise_price":3.7143,"expiration_date":"2024-12-03","underlying":"Common Stock","underlying_shares":4083},"source":{"system":"sec-edgar","filing":"0001127602-18-011460","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218011460/form4a.xml","form_type":"4/A","original_submission_date":"2018-03-12"}},{"id":3997521,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-03-13T22:25:50.000Z","date":"2018-03-08","kind":"sale","acquired":false,"shares":4083,"price":18.1028,"value":73913.7324,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $17.69-$18.50, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-18-011460","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218011460/form4a.xml","form_type":"4/A","original_submission_date":"2018-03-12"}},{"id":3997520,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-03-13T22:25:50.000Z","date":"2018-03-08","kind":"exercise","acquired":true,"shares":4083,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4083,"source":{"system":"sec-edgar","filing":"0001127602-18-011460","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218011460/form4a.xml","form_type":"4/A","original_submission_date":"2018-03-12"}},{"id":4000517,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144115,"kind":"person","name":"Voytas Daniel F","position":1,"cik":"0001712191","reported_name":"Voytas Daniel F","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-13T01:49:48.000Z","date":"2018-03-08","kind":"sale","acquired":false,"shares":4083,"price":18.1028,"value":73913.7324,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 8 is weighted average price. These shares were sold in multiple transactions at prices ranging from $17.69-$18.50, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option to purchase shares of Calyxt, Inc. common stock (\"Stock Option\") was granted on December 3, 2014, and vests 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vesting quarterly in equal installments over the following three years (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017."}],"balance_after":44917,"derivative":{"exercise_price":3.7143,"expiration_date":"2024-12-03","underlying":"Common Stock","underlying_shares":4083},"source":{"system":"sec-edgar","filing":"0001127602-18-011290","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218011290/form4.xml","form_type":"4"}}]}